← Leaderboards
Adam B Glick
Basic Sciences
$4,201,575
Attributed
$4,201,575
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $456.3K · FY2006–21$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,201,575 · 5
By mechanism
R01$3,801,567 · 3
R21$390,008 · 1
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionTranscription FactorKeratinocyteTumor Suppressor ProteinsTumorCarcinogenesisMalignant NeoplasmsSignal TransductionOncogenesMouse ModelResponseBaseCellsNeoplastic CellOncogenicIn VivoRas OncogeneIn VitroPathway InteractionsTumor ProgressionMalignant PhenotypeMediatingNeoplasm /Cancer GeneticsTransforming Growth Factors
Grant awards (28)
IRE1a: a Conditional Tumor Suppressor$146,229
R01 · FY2021 · CA · contact PI
IRE1a: a Conditional Tumor Suppressor$330,625
R01 · FY2020 · CA · contact PI
IRE1a: a Conditional Tumor Suppressor$215,551
R01 · FY2019 · CA · contact PI
IRE1a: a Conditional Tumor Suppressor$350,043
R01 · FY2018 · CA · contact PI
IRE1a: a Conditional Tumor Suppressor$350,367
R01 · FY2017 · CA · contact PI
IRE1a: a Conditional Tumor Suppressor$359,595
R01 · FY2016 · CA · contact PI
Suppression of Cancer Inflammation with AHR Modulators$211,285
R21 · FY2013 · ES · contact PI
Suppression of Cancer Inflammation with AHR Modulators$178,723
R21 · FY2012 · ES · contact PI
A Mouse model of TGFbeta1 and ras oncogene interactions$238,266
R01 · FY2010 · CA · contact PI
Ninth International Skin Carcinogenesis Conference (ISCC)$10,000
R13 · FY2010 · CA · contact PI
A Mouse model of TGFbeta1 and ras oncogene interactions$239,514
R01 · FY2009 · CA · contact PI
A Mouse Model of TGFB1 and Tumor Immunosurveillance in Squamous Cell Cancer$214,522
R01 · FY2009 · CA · contact PI
A Mouse model of TGFbeta1 and ras oncogene interactions$240,628
R01 · FY2008 · CA · contact PI
A mouse model of TGFbeta1 and tumor immunosurveillance in Squamous cell cancer$215,636
R01 · FY2008 · CA · contact PI
A Mouse model of TGFbeta1 and ras oncogene interactions$239,544
R01 · FY2007 · CA · contact PI
A mouse model of TGFbeta1 and tumor immunosurveillance in Squamous cell cancer$214,552
R01 · FY2007 · CA · contact PI
A Mouse model of TGFbeta1 and ras oncogene interactions$236,057
R01 · FY2006 · CA · contact PI
A Mouse Model of TGFB1 and Tumor Immunosurveillance in Squamous Cell Cancer$210,438
R01 · FY2006 · CA · contact PI
Mechanisms of Tumor Suppression by TGFbeta$0
Z01 · FY2004 · BC
Development of Models for Inducible Gene Expression$0
Z01 · FY2004 · BC
Models for Inducible Gene Expression in Epide$0
Z01 · FY2003 · BC
Mechanisms of Tumor Suppression by TGFB$0
Z01 · FY2003 · BC
Development and Utilization of Models for Inducible Gene$0
Z01 · FY2002 · BC
Mechanisms of Tumor Suppression by Transforming Growth F$0
Z01 · FY2002 · BC
Development and Utilization of Models for Inducible Gene$0
Z01 · FY2001 · BC
Mechanisms of Tumor Suppression by Transforming Growth F$0
Z01 · FY2001 · BC
Development and Utilization of Models for Inducible Gene Expression in the Epide$0
Z01 · FY2000 · BC
Mechanisms of Tumor Suppression by Transforming Growth Factor<FONT FACE=symbol>b$0
Z01 · FY2000 · BC